Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Inclusion Criteria: * The patient had a mild (Glasgow Coma Scale \[GCS\] score 13-15) or moderate (GCS score 9-12) closed TBI at the time of the injury, and the injury occurred 1 to 10 years prior to screening. * The patient had a Glasgow Outcome Scale score of 5 at the screening visit. * The patient had an Epworth Sleepiness Scale (ESS) score of at least 10 at screening. * The patient had a mean sleep latency on the Multiple Sleep Latency Test (MSLT) (average of 4 naps) of less than 8 minutes at baseline. * The patient had a Clinical Global Impression of Severity of Illness (CGI-S) rating relating to their excessive sleepiness of 4 or more at the screening and baseline visits. * The patient had a complaint of excessive sleepiness (at least 5 days/week on average) for at least 3 months, and the excessive sleepiness began within 12 months of the TBI. * Written informed consent was obtained. * The patient was a man or woman of any ethnic origin 18 to 65 years of age. * If admitted to an inpatient treatment facility, the patient was discharged at least 1 month prior to the screening visit. * The patient did not have any medical or psychiatric disorders that could account for the excessive sleepiness. * Women of childbearing potential (not surgically sterile or 2 years postmenopausal), used a medically accepted method of contraception, and continued use of one of these methods for the duration of the study (and for 30 days after participation in the study). Acceptable methods of…